# Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System

> **NCT00001365** · PHASE2 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 42 (—)

## Conditions studied

- Neurodegenerative Disease
- Parkinson's Disease

## Interventions

- **DRUG:** dextromethorphan

## Key facts

- **NCT ID:** NCT00001365
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-07
- **Primary completion:** —
- **Final completion:** 2001-06
- **Target enrollment:** 42 (—)
- **Last updated:** 2006-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001365, "Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00001365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*